Oyster Point Pharma, Inc. Earnings History by Quarter
Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
---|---|---|---|---|---|---|
11/10/2022 | Q3 2022 | -$1.53 | -$1.50 | 0.03 | $5.59 M | |
08/11/2022 | Q2 2022 | -$1.66 | -$1.99 | -0.33 | $4.69 M | |
05/05/2022 | Q1 2022 | -$1.74 | -$1.91 | -0.17 | $2.70 M | |
02/24/2022 | Q4 2021 | -$1.39 | -$1.71 | -0.32 | $6.60 M | |
11/04/2021 | Q3 2021 | -$1.16 | -$0.68 | 0.48 | $17.94 M | |
08/05/2021 | Q2 2021 | -$0.85 | -$0.85 | 0 | $0 | |
05/06/2021 | Q1 2021 | -$0.91 | -$0.73 | 0.18 | $0 | |
02/18/2021 | Q4 2020 | -$0.79 | -$0.86 | -0.07 | $0 | |
11/05/2020 | Q3 2020 | -$0.74 | -$0.63 | 0.11 | $0 | |
08/05/2020 | Q2 2020 | -$0.80 | -$0.66 | 0.14 | $0 | |
05/11/2020 | Q1 2020 | -$1.06 | -$0.77 | 0.29 | $0 | |
02/27/2020 | Q4 2019 | -$0.58 | -$1.41 | -0.83 | $0 | |
12/03/2019 | Q3 2019 | -$0.51 | -$0.56 | -0.05 | $0 | |
06/29/2019 | Q2 2019 | -$0.78 | $0 | |||
03/30/2019 | Q1 2019 | -$0.27 | $0 | |||
12/30/2018 | Q4 2018 | -$0.29 | $0 | |||
09/29/2018 | Q3 2018 | -$0.48 | $0 |
Oyster Point Pharma, Inc. Earnings: Frequently Asked Questions
-
Did Oyster Point Pharma, Inc. beat their earnings estimates last quarter?
In the previous quarter, Oyster Point Pharma, Inc. (:OYST) reported $-1.37 earnings per share (EPS) to beat the analysts' consensus estimate of $-1.53 by $0.16.
-
How can I listen to Oyster Point Pharma, Inc.'s earnings conference call?
The conference call for Oyster Point Pharma, Inc.'s latest earnings report can be listened to online.
-
How can I read Oyster Point Pharma, Inc.'s conference call transcript?
The conference call transcript for Oyster Point Pharma, Inc.'s latest earnings report can be read online.
-
How much revenue does Oyster Point Pharma, Inc. generate each year?
Oyster Point Pharma, Inc. (:OYST) has a recorded annual revenue of $24.54 M.
-
How much profit does Oyster Point Pharma, Inc. generate each year?
Oyster Point Pharma, Inc. (:OYST) has a recorded net income of $24.54 M. Oyster Point Pharma, Inc. has generated $-4.01 earnings per share over the last four quarters.
-
What is Oyster Point Pharma, Inc.'s price-to-earnings ratio?
Oyster Point Pharma, Inc. (:OYST) has a price-to-earnings ratio of -2.79 and price/earnings-to-growth ratio is 0.07.